Amicus Therapeutics, Inc. (FOLD) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Amicus Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -161.97x | -51.10x | -27.63x | -14.92x | -12.52x | -21.59x |
| P/B Ratio | 16.01x | 14.78x | 26.15x | 28.68x | 10.20x | 20.87x |
| P/S Ratio | 6.92x | 5.43x | 10.49x | 10.72x | 10.26x | 22.91x |
| Profitability | ||||||
| Gross Margin | 87.3% | 90.0% | 90.7% | 88.3% | 88.7% | 88.1% |
| Operating Margin | 5.4% | 4.7% | -19.3% | -64.4% | -67.6% | -94.7% |
| Net Margin | -4.3% | -10.6% | -38.0% | -71.9% | -82.0% | -106.1% |
| EBITDA Margin | 8.5% | 5.6% | -23.1% | -60.6% | -66.4% | -93.1% |
| Liquidity | ||||||
| Current Ratio | 2.84x | 3.39x | 2.88x | 3.05x | 4.09x | 4.47x |
| Quick Ratio | 1.88x | 2.60x | 2.52x | 2.88x | 3.90x | 4.32x |
| Leverage | ||||||
| Debt/Equity | 1.76x | 2.29x | 2.78x | 3.67x | 1.43x | 1.54x |
YoY = year-over-year change. Source: FMP..